The decision to pivot towards the Femtech sector could be seen positively by investors, as it represents a strategic move to diversify and tap into a rapidly growing market. The suspension of the cannabis facility construction, while a significant shift, is justified by the company due to market and security concerns, which could mitigate negative investor sentiment. The company's existing expertise in software and manufacturing, along with the planned expansion into Femtech, could open new revenue streams and potentially enhance its stock value in the short term.